^
+ Follow HEDGEHOG PATHWAY INHIBITOR Tag
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 671055
                    [Title] => Roche announces positive results for severe skin cancer medicine
                    [Summary] => 

BASEL, Switzerland — Roche announced this week that a pivotal Phase II clinical study of its investigational Hedgehog Pathway Inhibitor, vismodegib, showed positive results in people with advanced basal cell carcinoma (aBCC), a particularly severe and debilitating form of skin cancer.

[DatePublished] => 2011-03-31 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
HEDGEHOG PATHWAY INHIBITOR
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 671055
                    [Title] => Roche announces positive results for severe skin cancer medicine
                    [Summary] => 

BASEL, Switzerland — Roche announced this week that a pivotal Phase II clinical study of its investigational Hedgehog Pathway Inhibitor, vismodegib, showed positive results in people with advanced basal cell carcinoma (aBCC), a particularly severe and debilitating form of skin cancer.

[DatePublished] => 2011-03-31 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
abtest
Are you sure you want to log out?
X
Login

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

Get Updated:

Signup for the News Round now

FORGOT PASSWORD?
SIGN IN
or sign in with